European Union Suspends Roche HIV Drug Due to Toxic Contamination

Breaking Research: Read or Listen to the Latest Reports From ICAAC/IDSA 2008 >>

BROWSE ALL TOPICS:

U.S. Centers for Disease Control and Prevention • International News

European Union Suspends Roche HIV Drug Due to Toxic Contamination

August 7, 2007

In an announcement today, the European Commission said it had suspended Roche's license to market its HIV drug Viracept in the European Union. The drug was withdrawn from the market in June after Roche said some batches were contaminated with ethyl mesilate, which can cause tumors. The commission said the latest action is based on the counsel of the European Medicines Agency and member nations.

Back to other news for August 2007

Search the Newsroom archive

Excerpted from:
Agence France Presse
8.07.2007

This article was provided by U.S. Centers for Disease Control and Prevention, and is a part of the publication CDC HIV/Hepatitis/STD/TB Prevention News Update.

The Body PRO is a service of Body Health Resources Corporation, 250 West 57th Street, New York, NY 10107. The Body PRO and its logos are trademarks of Body Health Resources Corporation, which owns the copyright of The Body PRO's homepage, topic pages, page designs and HTML code. General Disclaimer: The Body PRO is designed for educational purposes only and is not engaged in rendering medical advice or professional services. The information provided through The Body PRO should not be used for diagnosing or treating a health problem or a disease. It is not a substitute for professional care. If you have or suspect you may have a health problem, consult your health care provider.